Fogliani, Rossella Righini, Grazia Lugli, Mario
Published in
Clinical Microbiology and Infection
Objectives Sex differences in COVID-19 severity and mortality have been described. Key aims of this analysis were to compare the risk of invasive mechanical ventilation (IMV) and mortality by sex and to explore whether variation in specific biomarkers could mediate this difference. Methods This was a retrospective, observational cohort study among ...
L’Huillier, Arnaud G. Meyer, Benjamin Andrey, Diego O. Arm-Vernez, Isabelle Baggio, Stephanie Didierlaurent, Arnaud Eberhardt, Christiane S. Eckerle, Isabella Grasset-Salomon, Carole Huttner, Angela
...
Published in
Clinical Microbiology and Infection
Objective To longitudinally evaluate the persistence of humoral immunity up to six months in a cohort of hospital employees with mild COVID-19. Methods We measured anti-RBD, -N and neutralizing antibodies at one, three and six months after mostly mild COVID-19 in 200 hospital workers using commercial ELISAs and a surrogate virus neutralization assa...
Huang, Zhilian Guo, Huiling YeeFen Lim, Hannah Chow, Angela
Published in
Clinical Microbiology and Infection
Smit, Mikaela Marinosci, Annalisa Agoritsas, Thomas Ford, Nathan Calmy, Alexandra
Published in
Clinical Microbiology and Infection
Background While the landscape of vaccine and treatment candidates against the novel coronavirus (COVID-19) has been reviewed systematically, prophylactic candidates remain unexplored. Objectives Map pre- and post-exposure prophylactic (PrEP and PEP) candidate for COVID-19. Data sources PubMed/Medline, Embase, International Committee of Medical Jou...
de l’Escalopier, Nicolas Mathieu, Laurent Duret, Christophe Banzet, Sébastien Genêt, François Salga, Marjorie
Published in
Clinical Microbiology and Infection
Like Stoira et al., we have experienced a high prevalence of troublesome HO in severe COVID patients. We would like to respond to the letter « High prevalence of heterotopic ossification in critically ill patients with severe COVID-19 » to give the point of view of an experienced medicosurgical team in charge of neurogenic Heterotopic Ossification ...
Antonin Bal, Trabaud, Mary-Anne Fassier, Jean-Baptiste Rabilloud, Muriel Saker, Kahina Langlois-Jacques, Carole Guibert, Nicolas Adèle Paul, Alfaiate, Dulce Massardier-Pilonchery, Amélie
...
Published in
Clinical Microbiology and Infection
Eyal, Nir Lipsitch, Marc
Published in
Clinical Microbiology and Infection
Background A vaccine trial with a conventional challenge design can be very fast once it starts, but it requires a long prior process, in part to grow and standardize challenge virus in the laboratory. This detracts somewhat from its overall promise for accelerated efficacy testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vac...
Feehan, Amy K. Fort, Daniel Velasco, Cruz Burton, Jeffrey H. Garcia-Diaz, Julia Price-Haywood, Eboni G. Sapp, Eric Pevey, Dawn Seoane, Leonardo
Published in
Clinical Microbiology and Infection
Image 1
Nguyen, Nhu Ngoc Hoang, Van Thuan Lagier, Jean-Christophe Raoult, Didier Gautret, Philippe
Published in
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
In the present study, we aimed to assess recovery rates at more than six months post-onset of anosmia and ageusia due to COVID-19 infection. Patients who reported anosmia and/or ageusia at the acute phase of a COVID-19 PCR-confirmed episode were retrospectively identified from a cohort of 3,737 patients seen at Hospital University institute, Marsei...
Cevik, Muge Haque, Syed Arefinul Manne-Goehler, Jennifer Kuppalli, Krutika Sax, Paul E Majumder, Maimuna S Orkin, Chloe
Published in
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
We aimed to compare the gender distribution of clinical trial leadership in COVID-19 clinical trials. We searched https://clinicaltrials.gov/and retrieved all clinical trials on COVID-19 from January 1, 2020 to June 26, 2020. As a comparator group, we have chosen two fields that are not related to emerging infections and infectious diseases: and co...
